« Previous
Next »
Surgery for Obesity and Related Diseases
Volume 6, Issue 3
, Pages 322-325
, May 2010
Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery
References
- . The incidence of clinical postoperative thrombosis after gastric surgery for obesity during 16 years. Obes Surg. 1997;7:332–336
- . Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg. 2003;13:819–825
- . Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg. 2000;10:7–14
- . The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc. 2008;22:2384–2391
- . Incidence of venous thromboembolism: a community-based study in Western France. Thromb Haemost. 2000;83:657–660
- Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975–980
- Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001;135:858–869
- . Prophylaxis of venous thromboembolism in bariatric surgery. Chir Ital. 2007;59:331–335
- Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2004;18:1082–1084
- . Duration of venous thromboembolism prophylaxis after surgery. Chest. 2003;124(6 Suppl):386S–392S
- . A simple venous thromboembolism prophylaxis protocol for patients undergoing bariatric surgery. Obesity (Silver Spring). 2006;14:1961–1965
- Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):338S–400S
- . Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):188S–203S
- . Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism. Haemostasis. 2001;31:42–48
- . Effect of prophylactic dalteparin on anti-factor Xa levels in morbidly obese patients after bariatric surgery. Obes Surg Epub. 2008 Oct 18;
- . Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin. Obes Surg. 2008;18:162–166
- . How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? (A laboratory perspective). Lab Hematol. 2005;11:157–162
- . A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12:19–24
PII: S1550-7289(10)00109-7
doi: 10.1016/j.soard.2010.02.046
© 2010 American Society for Metabolic and Bariatric Surgery. All rights reserved.
« Previous
Next »
Surgery for Obesity and Related Diseases
Volume 6, Issue 3
, Pages 322-325
, May 2010

